Stonepine Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,535,674
Closed -$27.4M 28
2023
Q1
$27.4M Buy
6,535,674
+1,601,574
+32% +$6.73M 9.21% 3
2022
Q4
$29.7M Sell
4,934,100
-735,288
-13% -$4.42M 12.47% 3
2022
Q3
$33M Buy
5,669,388
+1,988,193
+54% +$11.6M 14.83% 3
2022
Q2
$22M Sell
3,681,195
-1,003,209
-21% -$5.99M 10.23% 2
2022
Q1
$21.9M Sell
4,684,404
-4,115,954
-47% -$19.2M 9.07% 2
2021
Q4
$21.8M Buy
8,800,358
+836,029
+10% +$2.07M 10.02% 2
2021
Q3
$23.5M Buy
7,964,329
+331,799
+4% +$979K 10.69% 2
2021
Q2
$19.1M Buy
7,632,530
+4,339,111
+132% +$10.8M 9.98% 3
2021
Q1
$9.58M Buy
3,293,419
+1,239,419
+60% +$3.61M 5.18% 7
2020
Q4
$6.61M Sell
2,054,000
-1,714,597
-45% -$5.52M 5.06% 6
2020
Q3
$8.1M Sell
3,768,597
-299,594
-7% -$644K 8.43% 4
2020
Q2
$4.72M Sell
4,068,191
-2,362,446
-37% -$2.74M 9.14% 3
2020
Q1
$5.92M Buy
6,430,637
+2,675,637
+71% +$2.46M 6.26% 3
2019
Q4
$5.93M Buy
3,755,000
+43,001
+1% +$67.9K 4.14% 7
2019
Q3
$3.11M Sell
3,711,999
-192,401
-5% -$161K 3.02% 13
2019
Q2
$3.36M Sell
3,904,400
-95,600
-2% -$82.1K 2.31% 16
2019
Q1
$3.88M Sell
4,000,000
-1,726,579
-30% -$1.68M 2.23% 14
2018
Q4
$4.2M Buy
5,726,579
+424,516
+8% +$311K 3.69% 13
2018
Q3
$11.5M Buy
5,302,063
+1,252,765
+31% +$2.71M 6.7% 5
2018
Q2
$20.2M Sell
4,049,298
-1,092,448
-21% -$5.44M 12.25% 2
2018
Q1
$20.1M Buy
5,141,746
+3,306,908
+180% +$12.9M 10.75% 2
2017
Q4
$4.92M Buy
1,834,838
+841,838
+85% +$2.26M 2.95% 14
2017
Q3
$3.17M Sell
993,000
-1,291,381
-57% -$4.12M 1.87% 15
2017
Q2
$7.56M Buy
+2,284,381
New +$7.56M 4.08% 11
2017
Q1
Sell
-261,714
Closed -$1.07M 26
2016
Q4
$1.07M Buy
+261,714
New +$1.07M 0.64% 22
2016
Q2
Sell
-374,334
Closed -$1.99M 28
2016
Q1
$1.99M Sell
374,334
-695,528
-65% -$3.7M 2.35% 10
2015
Q4
$13.2M Buy
+1,069,862
New +$13.2M 15.42% 2